Try
Sartorius Aktiengesellschaft
SRT3Germany
31 filed reports · 275 financial concepts · 24 earnings calls · 0 media appearances
Filed reports
31 reports · Jun 2016 to Jun 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Half YearBundesanzeiger | 11 | 693 | Jun 2016 to Jun 2026 |
| AnnualBundesanzeiger | 8 | 728 | Dec 2021 to Dec 2025 |
| Q3Bundesanzeiger | 7 | 804 | Sep 2016 to Sep 2024 |
| Q1Bundesanzeiger | 5 | 295 | Mar 2022 to Mar 2026 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | half year | Jun 30, 2026 | Jun 30, 2026 | 75 | Open |
| FY2026 Q1 | q1 | Mar 31, 2026 | Apr 23, 2026 | 79 | Open |
| FY2025 | annual | Dec 31, 2025 | Dec 31, 2025 | 140 | Open |
| FY2025 Q2 | half year | Jun 30, 2025 | Jun 30, 2025 | 8 | Open |
| FY2025 Q1 | q1 | Mar 31, 2025 | Apr 16, 2025 | 102 | Open |
| FY2024 | annual | Dec 31, 2024 | Dec 31, 2024 | 138 | Open |
| FY2024 Q3 | q3 | Sep 30, 2024 | Oct 17, 2024 | 136 | Open |
| FY2024 Q2 | half year | Jun 30, 2024 | Jun 30, 2024 | 9 | Open |
| FY2024 Q1 | q1 | Mar 31, 2024 | Apr 18, 2024 | 64 | Open |
| FY2023 | annual | Dec 31, 2023 | Dec 31, 2023 | 19 | Open |
| FY2023 | annual | Dec 31, 2023 | Dec 31, 2023 | 133 | Open |
| FY2023 Q3 | q3 | Sep 30, 2023 | Oct 19, 2023 | 80 | Open |
Financial data
275 concepts · 2,520 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
IFRS206 concepts · 2,274 facts · Dec 2015 to Jun 2026
- Loans and borrowings36 · Jun 2016 to Jun 2026
- Other financial liabilities36 · Jun 2016 to Jun 2026
- Lease liabilities34 · Jun 2016 to Jun 2026
- Financial result33 · Jun 2016 to Jun 2026
- Other assets32 · Sep 2016 to Jun 2026
- Cash flow hedges30 · Jun 2016 to Mar 2026
- Currency translation differences30 · Jun 2016 to Mar 2026
- Income tax on cash flow hedges30 · Jun 2016 to Mar 2026
- Sales revenue30 · Jun 2016 to Dec 2025
- Total comprehensive income30 · Jun 2016 to Mar 2026
- - of which reclassified to profit or loss28 · Jun 2016 to Mar 2026
- Earnings per ordinary share (€) (basic)27 · Jun 2016 to Dec 2025
- Earnings per preference share (€) (basic)27 · Jun 2016 to Dec 2025
- Net profit for the period27 · Jun 2016 to Mar 2026
- Pretax Income26 · Jun 2016 to Jun 2026
- Remeasurements of the net defined benefit liability26 · Jun 2016 to Mar 2026
- Income tax on net investment in a foreign operation25 · Jun 2016 to Dec 2025
- Earnings before interest and taxes (EBIT)22 · Jun 2016 to Dec 2025
- Cash and cash equivalents at the end of the period21 · Jun 2016 to Jun 2026
- Change in cash and cash equivalents21 · Jun 2016 to Jun 2026
- Net effect of currency translation on cash and cash equivalents21 · Jun 2016 to Jun 2026
- Net result⁵21 · Jun 2017 to Mar 2025
- Cash and Equivalents20 · Jun 2016 to Jun 2026
- Financing Cash Flow20 · Jun 2016 to Mar 2026
Segment14 concepts · 119 facts · Jun 2016 to Jun 2026
- Order intake29 · Jun 2016 to Jun 2020
- EBITDA¹26 · Jun 2016 to Jun 2020
- Sales revenue10 · Jun 2017 to Sep 2024
- Underlying EBITDA10 · Jun 2017 to Jun 2026
- Goodwill8 · Dec 2021 to Dec 2025
- Americas26 · Jun 2018 to Jun 2020
- EBITDA-Margin3) in %6 · Jun 2019 to Sep 2019
- EMEA26 · Jun 2018 to Jun 2020
- Underlying EBITDA margin in %5 · Jun 2017 to Jun 2020
- Asia | Pacific24 · Jun 2018 to Jun 2020
- Total3 · Jun 2019 to Jun 2020
- Cost of Revenue2 · Jun 2026
- R&D Expense2 · Jun 2026
- Selling and distribution expenses2 · Jun 2026
GAAP41 concepts · 67 facts · Dec 2021 to Dec 2023
- 12. Profit after tax3 · Dec 2021 to Dec 2023
- 13. Other taxes3 · Dec 2021 to Dec 2023
- 14. Net profit for the period3 · Dec 2021 to Dec 2023
- 15. Profit brought forward3 · Dec 2021 to Dec 2023
- 1. Sales revenue3 · Dec 2021 to Dec 2023
- 2. Other operating income3 · Dec 2021 to Dec 2023
- 6. Income from investments – Of which from affiliated companies 46,270 (2020: 23,273) –3 · Dec 2021 to Dec 2023
- 7. Profit received under a profit and loss transfer agreement3 · Dec 2021 to Dec 2023
- 9. Interest and similar income – Of which from affiliated companies 17,773 (2020: 12,948) –3 · Dec 2021 to Dec 2023
- Income Tax Expense (Benefit)3 · Dec 2021 to Dec 2023
- 4. Depreciation of property, plant and equipment and amortization of intangible assets2 · Dec 2022 to Dec 2023
- 5. Other operating expenses2 · Dec 2022 to Dec 2023
- 7. Income from long-term loans2 · Dec 2022 to Dec 2023
- 8. Loss accepted under a profit and loss transfer agreement2 · Dec 2021 to Dec 2022
- a) Salaries2 · Dec 2022 to Dec 2023
- Interest Expense2 · Dec 2022 to Dec 2023
- 10. Write downs on financial assets and short-term investments1 · Dec 2023
- 1. Land and leasehold rights and improvements, including buildings on third-party land1 · Dec 2021
- 1. Receivables from affiliated companies1 · Dec 2021
- 1. Shares in affiliated companies1 · Dec 2021
- 2. Factory and office equipment and other equipment1 · Dec 2021
- 2. Loans to affiliated companies1 · Dec 2021
- 3. Investments (participating interest)1 · Dec 2021
- Ancillary staff costs1 · Dec 2021
APM13 concepts · 58 facts · Sep 2016 to Jun 2025
- per ordinary share in €11 · Sep 2016 to Jun 2025
- per preference share in €11 · Sep 2016 to Jun 2025
- Underlying earnings after taxes and non-controlling interest10 · Sep 2016 to Jun 2025
- Normalized financial result²7 · Sep 2016 to Jun 2025
- Normalized income tax (27%)³5 · Sep 2016 to Jun 2025
- Extraordinary effects2 · Sep 2016 to Sep 2017
- M&A projects | integration costs2 · Jun 2023 to Jun 2024
- Other2 · Jun 2023 to Jun 2024
- Structural measures2 · Jun 2023 to Jun 2024
- Total2 · Jun 2023 to Jun 2024
- Underlying net result after tax2 · Sep 2016 to Sep 2017
- Amortization1 · Sep 2016
- Non-controlling interest1 · Sep 2016
KPI1 concepts · 2 facts · Mar 2023 to Mar 2024
- Number of employees worldwide2 · Mar 2023 to Mar 2024
Segments
119 factsFigures broken down by business line, region, product or another axis the company reports on.
Business segment4 members · 119 facts
- Bioprocess Solutions56 · Jun 2016 to Jun 2026
- Lab Products & Services52 · Jun 2016 to Jun 2026
- 6-mo.6 · Jun 2018
- Sales revenue5 · Jun 2017 to Jun 2020
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
24 calls · Apr 2018 to Jul 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Jul 23, 2026
- FY2025 Q4Feb 3, 2026
- FY2025 Q2Jul 22, 2025
- FY2025 Q1Apr 16, 2025
- FY2024 Q4Jan 28, 2025
- FY2024 Q3Oct 17, 2024
- FY2024 Q1Apr 18, 2024
- FY2023 Q4Jan 26, 2024
- FY2023 Q2Jul 21, 2023
- FY2023 Q1Apr 20, 2023
- FY2022 Q4Jan 26, 2023
- FY2022 Q3Oct 19, 2022
- FY2022 Q2Jul 21, 2022
- FY2022 Q1Apr 21, 2022
- FY2021 Q4Jan 27, 2022
- FY2021 Q3Oct 20, 2021
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.